共 8 条
[1]
Targeted disruption of Smad3 results in imparired mucosalimmunity and diminished T cell responsiveness to TGF-beta. Yang X,Letterio J J,Chen L,et al. EMBO Journal . 1999
[2]
Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Kjellman C,Olofssn SP,Hansson O,et al. International Journal of Cancer . 2000
[3]
Immunocytochemical study of transforming growth factor expression in begin and malignant gliomas. Samuels V,Barrett JM,Bockman S,et al. American Journal of Pathology . 1989
[4]
Enhanced expression of transforming growth factor-beta and its type-Ⅰand type-Ⅱ receptors in humanglioblastoma. Yamada N,Kato M,Yamashita H,et al. International Journal of Cancer . 1995
[5]
TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cui W,Fowlis DJ,Bryson S,et al. Cell . 1996
[6]
The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancern. Kleeff J,Ishiwata T,Maruyama H,et al. Oncegene . 1999
[7]
Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in hunman hepatocellular carcinoma: implication for roles of smads in its growth. Atsuzaki K,Date M,Furukawa F,et al. Hepatology . 2000
[8]
Expression of transforminggrowth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1. Piek E,Westermark U,Kastemar M,et al. Cancer . 1999